Meet ApplyKite Twin, the application assistant that learns with you
Meet your Twin, it learns with you
Your Twin learns with you
Launch week codes:30% off annual Pro20% off monthly Pro
Ends in00h00m00s
Ends in00h00m00s
Arto Urtti
Just Landed
New Today
Doctoral Researcher (PhD student), Pathomechanisms and Novel Drug Optimization for AMD (MSCA-DN) University of Eastern Finland in Finland
Degree Level
PhD
Field of study
Chemistry
Funding
MSCA-funded doctoral position with a gross salary of approximately EUR 4,390 per month including the mobility allowance, or approximately EUR 4,940 per month if eligible for the family allowance.
Deadline
Nov 30, 2026
Country
Finland
University
University of Eastern Finland
Apply for this position
Keywords
Suggested positions
Aston University
United Kingdom
1 month ago
PhD opportunity at Aston University in Birmingham, United Kingdom on bioerodible inserts for controlled ocular drug delivery . The project sits in the School of Medicine, Pharmacy and Biosciences and focuses on developing antibiotic-loaded ocular inserts as a platform for sustained and controlled release of medicines for eye disease. The research is centered on ocular drug delivery , pharmaceutical formulation , controlled release , quality by design (QbD) , and biological/physico-chemical chara...
1 month ago
University of Basel
Switzerland
1 month ago
PhD opportunity at the University of Basel, Switzerland in rationally engineered hydrogels for controlling osteogenesis via mechanoregulation . This interdisciplinary project, hosted by the Swiss Nanoscience Institute , combines biomedical engineering , materials science , biology , chemistry , and computational modelling . The research aims to design multifunctional culture matrices with tunable viscoelastic properties, study how hydrogel mechanics influence human dental pulp stem cell differen...
1 month ago
George Washington University
United States
2 weeks ago
George Washington University is advertising a Postdoctoral Associate position in the Chemistry Department focused on the design, synthesis, characterization, and evaluation of novel antibiotics and their prodrugs . The role is based at the Foggy Bottom campus in Washington, D.C., United States , and is an on-campus/in-person appointment. This postdoctoral research opportunity is centered on advanced experimental work in chemistry and drug discovery. The scientist will work with the PI, undergrad...
2 weeks ago
Seungkuk Ahn
University College Dublin
Ireland
3 weeks ago
University College Dublin is advertising a 36-month postdoctoral position (PD level 1) in the Charles Institute of Dermatology with Associate Professor Seungkuk Ahn . The project is supported by an ERC grant and focuses on ECM hydrogels , organoids , human stem cell fate decisions , and organoid morphogenesis . The successful candidate will help develop species- and sex-specific 3D ECM hydrogels and study how these materials influence stem cell behavior and organoid development. This is a strong...
3 weeks ago
University at Buffalo
United States
3 weeks ago
Postdoctoral Associate in Pharmaceutical Sciences at the University at Buffalo (Research Foundation / Department of Pharmaceutical Sciences). The lab is seeking a highly motivated postdoctoral researcher to work on nanomedicines and drug delivery , with opportunities to develop new directions in antibody drug conjugates for treating cancer and inflammatory diseases . This position is a strong fit for candidates with training in cell biology , pharmacology , bioengineering , polymer chemistry , o...
3 weeks ago
About this position
This doctoral project is part of the European Commission’s PANDORA Doctoral Network and is hosted by the School of Pharmacy, Faculty of Health Sciences at the University of Eastern Finland in Kuopio. The researcher will work on pathomechanisms and novel drug optimization for age-related macular degeneration (AMD), with a strong emphasis on ophthalmic drug delivery to the retina.
The core research task is to develop and test intravitreal drug formulations designed for targeted retinal delivery. The project aims to generate long-acting, safe, and stable formulations for intravitreal injections using compounds supplied by consortium partners. A central part of the work will be the creation of hydrogel and nanoformulations to improve ocular retention and control drug release.
The doctoral researcher will use a broad methodological toolkit spanning formulation science, biology, and quantitative analysis. This includes:
- physico-chemical manufacturing and characterization of drug delivery systems
- microfluidics, nanoparticle tracking analysis, and rheological methods
- cell culture assays for toxicity and drug potency
- experimental pharmacokinetics with rodents and rabbits
- quantitative LC-MS/MS analytics
- computational data analysis and pharmacokinetic simulations
The project is embedded in an active ocular drug delivery environment known for pharmaceutical and biomedical research. The advert highlights the University of Eastern Finland as a leading centre for ocular drug delivery research, with multiple research groups working in the field, modern laboratories and equipment, and opportunities to engage with an international network of experts. The PANDORA network also offers secondments with partner labs, together with training activities and exposure to research areas such as gene therapy, pharmacology, bioinformatics, disease modelling, and imaging.
The research focus is directly relevant to AMD treatment development and includes testing therapeutic approaches such as complement inhibition, antioxidants, anti-inflammatory drugs, and mitochondria modulators. The overall goal is to support the design of new therapeutic strategies for impaired vision through advanced ocular drug delivery research.
Professor Arto Urtti is listed as the contact person for further information on the position.
Funding details
MSCA-funded doctoral position with a gross salary of approximately EUR 4,390 per month including the mobility allowance, or approximately EUR 4,940 per month if eligible for the family allowance.
What's required
A Master’s (or equivalent) degree in life sciences or chemistry, including pharmacy, cell biology, polymer chemistry or closely related fields is required. The applicant must have excellent oral and written English skills with good presentation skills, high motivation and interest in retinal pharmacology and drug delivery, and the ability to work both independently and as part of a team. Knowledge of cellular biology, eye biology and/or pharmacology is expected, along with hands-on experience in quantitative chemical analyses and biological research. Experience in animal experiments, biomaterials/nanomedicine, and computational pharmacology is considered an advantage. MSCA mobility rules apply: the applicant must not have resided or carried out their main activity in Finland for more than 12 months in the 36 months before recruitment and must not already hold a doctoral degree.
How to apply
Submit the application through the university’s electronic application form by 30 November 2026 at 23:59 Finnish time. Include the required CV, degree certificates, transcripts, Master’s thesis/publications if available, motivation letter, two recommendation letters, and any other supporting documents. If degree documents are not in English, provide official English translations.
ApplyKite TwinLearns as you applyMake your next move.
Prepare your application
Review drafts and confirm requirements with the university.
Professors
Professor at University of Eastern Finland
Finland
Research Interests
Pharmaceutical Chemistry
Biochemistry
Lipidomic
Nanomedicine
Materials Science
ApplyKite TwinLearns as you applyMake your next move.
Prepare your application
Review drafts and confirm requirements with the university.